Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
ACE Report #7832
Ace Report Cover Osteoarthritis

IA injection of US-approved viscosupplements safe and effective at 26 weeks in knee OA

Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:N/A

Safety and efficacy of US-approved viscosupplements for knee osteoarthritis: a systematic review and meta-analysis of randomized, saline-controlled trials

J Pain Res. 2015 May 7;8:217-28

Contributing Authors: V Strand LF McIntyre WR Beach LE Miller JE Block

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


29 randomized controlled trials, with a total of 4,886 patients were included in this meta-analysis to analyze the safety and efficacy of US-approved viscosupplements in symptomatic knee osteoarthritis (OA) treatment. Results indicated that intra-articular injection of viscosupplements may be safe and effective through 26 weeks, as they resulted in large treatment effects for knee pain and functio...

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.